New approaches to the medical treatment of irritable bowel syndrome

被引：2

作者：

Driss Berrada

Katia Canenguez

Tony Lembo

机构：

[1] Department of Medicine, Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA 02215

来源：

Current Gastroenterology Reports | 2003年 / 5卷 / 4期

关键词：

Irritable Bowel Syndrome; Irritable Bowel Syndrome Patient; Loperamide; Tegaserod; Irritable Bowel Syndrome Symptom;

D O I：

10.1007/s11894-003-0072-0

中图分类号：

学科分类号：

摘要：

Irritable bowel syndrome (IBS) is a common disorder with a worldwide distribution; it is characterized by abdominal pain and discomfort associated with an alteration of bowel function. The treatment approach for IBS depends on the patient's presenting symptoms at the time of diagnosis, and treatment is usually directed toward the predominant symptom. In this review we discuss the current approach to the treatment of IBS. Copyright © 2003 by Current Science Inc.

引用

页码：337 / 342

页数：5

共 48 条

[1]

Saito Y.A., Schoenfeld P., Locke III G.R., The epidemiology of irritable bowel syndrome in North America: A systematic review, Am. J. Gastroenterol., 97, pp. 1910-1915, (2002)

[2]

Drossman D.A., Li Z., Andruzzi E., Et al., U.S. householder survey of functional gastrointestinal disorders: Prevalence, sociodemography, and health impact, Dig. Dis. Sci., 38, pp. 1569-1580, (1993)

[3]

Kay L., Jorgensen T., Jensen K.H., The epidemiology of irritable bowel syndrome in a random population: Prevalence, incidence, natural history and risk factors, J. Intern. Med., 236, pp. 23-30, (1994)

[4]

Drossman D.A., Whitehead W.E., Camilleri M., Irritable bowel syndrome: A technical review for practice guideline development, Gastroenterology, 112, pp. 2120-2137, (1997)

[5]

Switz D.M., What the gastroenterologist does all day: A survey of a state society's practice, Gastroenterology, 70, pp. 1048-1050, (1976)

[6]

Talley N.J., Gabriel S.E., Harmsen W.S., Et al., Medical costs in community subjects with irritable bowel syndrome, Gastroenterology, 109, pp. 1736-1741, (1995)

[7]

Akehurst R.L., Brazier J.E., Mathers N., Et al., Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting, Pharmacoeconomics, 20, pp. 455-462, (2002)

[8]

Shih Y.C., Barghout V.E., Sandler R.S., Et al., Resource utilization associated with irritable bowel syndrome in the United States 1987-1997, Dig. Dis. Sci., 47, pp. 1705-1715, (2002)

[9]

Thompson W.G., Longstreth G.F., Drossman D.A., Et al., Functional bowel disorders and functional abdominal pain, Gut, 45, SUPPL. II, (1999)

[10]

Cash B.D., Schoenfeld P., Chey W.D., The utility of diagnostic tests in irritable bowel syndrome patients: A systematic review, Am. J. Gastroenterol., 97, pp. 2812-2819, (2002)

← 1 2 3 4 5 →